WO2014185364A1 - ラクターゼ含有組成物の製造法 - Google Patents
ラクターゼ含有組成物の製造法 Download PDFInfo
- Publication number
- WO2014185364A1 WO2014185364A1 PCT/JP2014/062552 JP2014062552W WO2014185364A1 WO 2014185364 A1 WO2014185364 A1 WO 2014185364A1 JP 2014062552 W JP2014062552 W JP 2014062552W WO 2014185364 A1 WO2014185364 A1 WO 2014185364A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lactase
- protease
- containing composition
- milk
- exchange resin
- Prior art date
Links
- 102100026189 Beta-galactosidase Human genes 0.000 title claims abstract description 152
- 108010059881 Lactase Proteins 0.000 title claims abstract description 152
- 108010005774 beta-Galactosidase Proteins 0.000 title claims abstract description 152
- 229940116108 lactase Drugs 0.000 title claims abstract description 152
- 239000000203 mixture Substances 0.000 title claims abstract description 89
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 108091005804 Peptidases Proteins 0.000 claims abstract description 98
- 239000004365 Protease Substances 0.000 claims abstract description 97
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 93
- 239000003456 ion exchange resin Substances 0.000 claims abstract description 38
- 229920003303 ion-exchange polymer Polymers 0.000 claims abstract description 38
- 235000013336 milk Nutrition 0.000 claims abstract description 38
- 239000008267 milk Substances 0.000 claims abstract description 38
- 210000004080 milk Anatomy 0.000 claims abstract description 38
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000000243 solution Substances 0.000 claims abstract description 31
- 239000007864 aqueous solution Substances 0.000 claims abstract description 25
- 150000003839 salts Chemical class 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 15
- 230000000694 effects Effects 0.000 claims description 63
- 235000013365 dairy product Nutrition 0.000 claims description 18
- -1 inorganic acid salt Chemical class 0.000 claims description 16
- 239000003957 anion exchange resin Substances 0.000 claims description 15
- 244000005700 microbiome Species 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 description 25
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000020124 milk-based beverage Nutrition 0.000 description 11
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 10
- 239000008101 lactose Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 10
- 238000003860 storage Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 235000015140 cultured milk Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 241000235650 Kluyveromyces marxianus Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 241001138401 Kluyveromyces lactis Species 0.000 description 5
- 102000014171 Milk Proteins Human genes 0.000 description 5
- 108010011756 Milk Proteins Proteins 0.000 description 5
- 235000021239 milk protein Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000012266 salt solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 235000013618 yogurt Nutrition 0.000 description 5
- 102000011632 Caseins Human genes 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 4
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000003729 cation exchange resin Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 238000005342 ion exchange Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000235649 Kluyveromyces Species 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 238000005349 anion exchange Methods 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 229940023913 cation exchange resins Drugs 0.000 description 3
- 235000015243 ice cream Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000012089 stop solution Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000003014 ion exchange membrane Substances 0.000 description 2
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 235000020191 long-life milk Nutrition 0.000 description 2
- 239000011565 manganese chloride Substances 0.000 description 2
- 229940099607 manganese chloride Drugs 0.000 description 2
- 235000002867 manganese chloride Nutrition 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000000940 FEMA 2235 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003011 anion exchange membrane Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000015155 buttermilk Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 235000020152 coffee milk drink Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940039748 oxalate Drugs 0.000 description 1
- 235000020200 pasteurised milk Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 235000021246 κ-casein Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
- A23C9/1206—Lactose hydrolysing enzymes, e.g. lactase, beta-galactosidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01108—Lactase (3.2.1.108)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a method for producing a lactase-containing composition having a reduced protease content.
- Lactase is an enzyme that decomposes lactose into glucose and galactose. Lactose is present in dairy products using milk beverages such as milk, but lactase is present in many human small intestines, so that lactose in dairy products is broken down into glucose and galactose in the small intestine. However, there are some humans who do not work well with lactase, and lactose cannot be decomposed sufficiently, resulting in symptoms of diarrhea and indigestion. Lactase is widely used to break down lactose in dairy products. Lactase is also widely used for improving the sweetness of milk drinks and fermented milk, for producing ice cream and milk jam, and for imparting caramel color such as coffee milk.
- Such lactase is produced from yeast, mold, bacteria, and the like. Above all, it is produced by culturing yeasts such as Kluyveromyces lactis (K. lactis), Kluyveromyces fragilis (K. fragillis), Kluyveromyces marxianus (K. marxianus) and the like.
- yeasts such as Kluyveromyces lactis (K. lactis), Kluyveromyces fragilis (K. fragillis), Kluyveromyces marxianus (K. marxianus) and the like.
- K. lactis Kluyveromyces lactis
- K. fragillis Kluyveromyces fragilis
- Kluyveromyces marxianus K. marxianus
- Patent Documents 1 and 2 As means for reducing protease mixed in lactase, there is a report that it can be achieved by binding lactase to a chromatographic resin such as an ion exchange resin and then desorbing or eluting only lactase (Patent Documents 1 and 2). ).
- Non-patent Document 2 In order to obtain a pure lactase solution, it is necessary to remove a plurality of types of proteases contained in the bacterial cell extract. Since the properties of each protease are different, it is extremely difficult to remove a plurality of types of proteases by a single purification step. In order to obtain a pure lactase solution, there can be considered a means for removing proteases contained in the bacterial cell extract one by one through a plurality of purification steps.
- the lactase in order to obtain a pure lactase solution, the lactase is selectively eluted after adsorbing the lactase contained in the bacterial cell extract on multiple types of column chromatography.
- the operation is complicated and requires a large amount of equipment and the number of days of purification, which is not suitable as an industrial production method.
- the yield of lactase decreases as the number of purification steps increases.
- the present inventor has made various studies to develop means for removing the protease in the lactase-containing composition by a simple treatment, and dissolved the protease-containing lactase composition in a salt-containing aqueous solution having a certain electric conductivity. Later, if it is brought into contact with an ion exchange resin, the protease is selectively adsorbed unexpectedly and the lactase permeates, so that a lactase-containing composition with a reduced protease content can be obtained without any elution treatment. I found out.
- the dairy product formulated with the lactase-containing composition produced in this way is not only decomposed lactose but also does not generate off-flavor, has a good touch and has a storage stability. Has also been found to be good.
- the present invention provides the following [1] to [7].
- a composition containing lactase and protease is dissolved in a salt-containing aqueous solution having an electric conductivity of 2 to 45 mS / cm, and the resulting solution is brought into contact with an ion exchange resin to collect a fraction that is not adsorbed on the ion exchange resin.
- a method for producing a lactase-containing composition having a reduced protease content [2] The production method according to [1], wherein the composition containing lactase and protease is a lactase-containing composition produced by a microorganism. [3] The production method according to [1] or [2], wherein the salt-containing aqueous solution is an inorganic acid salt aqueous solution.
- a lactase-containing composition with reduced protease can be efficiently obtained simply by dissolving a protease-containing lactase composition in a salt-containing aqueous solution and bringing it into contact with an ion exchange resin.
- the lactase-containing composition obtained according to the present invention has a ratio of lactase activity to protease activity of 0.02% or less, and the protease activity is remarkably reduced. Even when stored for a long period of time, precipitation hardly occurs, no off-flavor of milk beverages is generated, and a completely unexpected effect of improving the touch of the resulting dairy product is obtained.
- Figure 6 shows SDS-PAGE results for milk treated with lactase-containing compositions at various protease proportions.
- Figure 3 shows milk curd of milk treated with lactase-containing compositions at various protease ratios (inverted after storage).
- the method for producing a lactase-containing composition with reduced protease content comprises (1) a step of dissolving a composition containing lactase and protease in a salt-containing aqueous solution having an electric conductivity of 2 to 45 mS / cm, and (2 And a step of bringing the obtained solution into contact with an ion exchange resin and collecting a fraction that is not adsorbed on the ion exchange resin.
- Examples of the composition containing lactase and protease used in step (1) include lactase-containing compositions obtained by culturing microorganisms that produce lactase.
- Examples of microorganisms that produce lactase include microorganisms belonging to the genus Kluyveromyces, Aspergillus, and Bacillus, and among these, microorganisms belonging to the genus Kluyveromyces are more preferable.
- microorganisms belonging to the genus Kluyveromyces Kluyveromyces fragilis (K. fragillis), Kluyveromyces lactis (K. lactis), Kluyveromyces marxianus (K.marxianus) are preferable, Iberomyces lactis is more preferred.
- the culture of the microorganism producing lactase is preferably carried out in a medium containing lactose or a nitrogen source, for example, under conditions of pH 3 to 10 and at 20 to 40 ° C. for 24 to 180 hours.
- a medium containing lactose or a nitrogen source for example, under conditions of pH 3 to 10 and at 20 to 40 ° C. for 24 to 180 hours.
- it may be extracted from the collected cells, or mutant cells that are discharged to the outside of the cell may be used.
- the culture solution itself may be used.
- the raw material lactase-containing composition may be a liquid containing a culture solution or a solid obtained by removing moisture from the culture solution.
- the lactase contained in the raw material lactase-containing composition may be deactivated, the cost of removing water is incurred, and the obtained solid is a salt aqueous solution described later.
- the raw material lactase-containing composition is preferably in a liquid form because it is difficult to redissolve it in the solution.
- the lactase used in the present invention is preferably one having an optimum pH of activity in a neutral region and having a property of being deactivated in an acidic region and capable of degrading lactose in an active state.
- the optimum pH for lactase activity is 6.0 to 7.5, and the inactivation pH is more preferably 4.0 to 6.0.
- the lactase used in the present invention does not substantially adsorb to the anion exchange resin in the presence of a specific aqueous salt solution described later. “Substantially not adsorbing” means that the lactase yield is 80% or more, preferably 85% or more, and more preferably 90% or more.
- the lactase yield is a value obtained by dividing 100 by the value obtained by dividing the total lactase activity after the ion-exchange resin treatment by the total lactase activity before the ion-exchange resin treatment (added with a salt-containing aqueous solution).
- the activity ratio (protease activity / lactase activity ⁇ 100; even if ordinary industrial purification means such as ultrafiltration is employed).
- protease ratio the activity ratio
- the reason for the protease ratio is that the value of each protease activity and lactase activity varies depending on the amount of solvent, and it is difficult to determine the value uniformly. This is because it is possible to show it without depending on the amount.
- the protease contained in the raw material lactase-containing composition means that detected by the method for measuring protease activity described later. That is, it means the total protease, not a specific protease.
- Proteases have the property of degrading peptides and proteins in the active state.
- Protease contained in the raw material lactase-containing composition has a property of being easily adsorbed to an anion exchange resin in the presence of a specific aqueous salt solution described later, and in particular has a property of adsorbing to a weakly basic anion exchange resin. Therefore, if a protease dissolved in a specific salt aqueous solution described later is adsorbed on the anion exchange resin, the protease maintains the state of being adsorbed on the anion exchange resin.
- the solution used for dissolving the raw material lactase-containing composition is a salt-containing aqueous solution having an electric conductivity of 2 to 45 mS / cm, because the protease in the raw material lactase-containing composition is selectively adsorbed on the ion exchange resin. is important. That is, the lactase contained in the solution permeates without being adsorbed on the ion exchange resin or is liberated after being adsorbed on the ion exchange resin.
- the electrical conductivity is preferably 10 to 45 mS / cm, more preferably 18 to 42 mS / cm, still more preferably 20 to 41 mS / cm, and further preferably 25 to 36 mS / cm.
- the means for dissolving the raw material lactase-containing composition in the aqueous salt solution varies depending on whether the raw material lactase-containing composition is liquid or solid at room temperature (25 ° C.).
- the raw material lactase-containing composition is liquid, 10 to 9900 parts by mass of the salt aqueous solution may be added to 100 parts by mass of the raw material lactase-containing composition.
- the amount is preferably 100 to 9900 parts by mass.
- the amount of the salt aqueous solution to be added is small, it is difficult to obtain the electric conductivity in a preferable range, and thus it is difficult to obtain the effect of the present invention.
- there are many salt aqueous solutions to add there exists a problem which requires processing time and becomes complicated.
- the salt aqueous solution may be added in an amount of 10 to 9900 parts by mass with respect to 100 parts by mass of the raw material lactase-containing composition as a solid.
- the amount is preferably 100 to 9900 parts by mass.
- the amount of the salt aqueous solution to be added is small, it is difficult to obtain the electric conductivity in a preferable range, and thus it is difficult to obtain the effect of the present invention.
- there are many salt aqueous solutions to add there exists a problem which requires processing time and becomes complicated.
- the lactase-containing composition is uniformly dissolved or dispersed by adding an aqueous salt solution.
- the salt contained in the salt-containing aqueous solution having an electric conductivity of 2 to 45 mS / cm may be an organic acid salt or an inorganic acid salt.
- an inorganic acid salt selectively adsorbs protease to an ion exchange resin and It is preferable from the viewpoint of easy collection of the lactase-containing composition that is the object.
- the organic acid salt include metal salts and amine salts of organic acids having a molecular weight of 70 to 300 such as acetate, citrate, malate, oxalate, and tartrate.
- inorganic acid salts include metal salts such as hydrochloric acid, nitric acid, sulfuric acid, hydrofluoric acid, carbonic acid, boric acid, and phosphoric acid, and amine salts. Of these, metal salts of inorganic acids are particularly preferred.
- the metal include alkali metals and alkaline earth metals.
- a salt may be used independently and may be used in mixture of multiple types.
- an inorganic acid salt aqueous solution of 0.02 to 0.42 M is preferably used. It is more preferable to use an aqueous solution of inorganic acid salt of ⁇ 0.37M, and it is further preferable to use an aqueous solution of inorganic acid salt of 0.2 to 0.32M.
- the lactase activity in the aqueous salt solution is preferably from 100 to 250,000 U / mL, more preferably from 500 to 120,000 U / mL, from a point of selectively adsorbing the protease to the ion exchange resin, and from 2,500 to 60, More preferred is 000 U / mL.
- Step (2) is a step of bringing the obtained solution into contact with an ion exchange resin and collecting a fraction that is not adsorbed on the ion exchange resin.
- Examples of ion exchange resins include cation exchange resins and anion exchange resins.
- Examples of the cation exchange resin include strong acid cation exchange resins (containing sulfonic acid groups) and weak acid cation exchange resins (containing carboxyl groups and phenolic hydroxy groups).
- Examples of the anion exchange resin include strong basic anion exchange resins (containing quaternary ammonium groups) and weak basic anion exchange resins (containing primary to tertiary amino groups). Among these, an anion exchange resin is preferable in terms of selective adsorptivity of protease, and a weakly basic anion exchange resin is more preferable.
- the base material of the ion exchange resin examples include those based on styrene-divinylbenzene, acrylic acid, cellulose, agarose, dextrin, dextran, polysulfone, polyacrylonitrile, polyethylene and the like.
- the shape of the ion exchange resin examples include powder, sphere, fiber, and membrane. From the viewpoint of ease of use, the ion exchange resin is preferably in the form of a sphere that can be packed in a column or in the form of a film, and more preferably in the form of a film because it can be carried out in a short time because it can be carried out more easily and at a high flow rate.
- ion exchange resins include Diaion SA series (strongly basic gel type: SA10A, 11A, 12A, 20A, 21A, etc., manufactured by Mitsubishi Chemical Corporation), PA series (strongly basic porous type; PA306, 308). , 312, 316, 318, 406, 408, 412, 416, 418, etc., manufactured by Mitsubishi Chemical Co., Ltd.), WA series (weakly basic acrylic type: WA10, 11, strong basic high porous type: WA20, 21, 30, etc.) , Mitsubishi Chemical Co., Ltd.), Amberlite IRA series (IRA-400, 410, 900, 93ZU, etc., manufactured by Mitsubishi Chemical Co., Ltd.), Mustang Q series (strongly basic ion exchange membrane: manufactured by Pall), QyuSpeed D series ( Weakly basic ion-exchange membrane: manufactured by Asahi Kasei Co., Ltd.).
- Diaion SA series strongly basic gel type: SA10A, 11A, 12A, 20A, 21A, etc., manufactured
- the means for bringing the solution into contact with the ion exchange resin varies depending on the form of the ion exchange resin, but after adding the ion exchange resin to the solution, stirring and adsorbing, the batch method of removing the ion exchange resin by filtration operation
- the column method and the membrane treatment method are more preferable.
- the protease in the solution is selectively adsorbed on the ion exchange resin, so that the liquid passing through the column or membrane (the fraction not adsorbed on the ion exchange resin) is collected.
- a lactase-containing composition having a reduced protease content can be obtained.
- the protease content is reduced means that the protease activity is reduced as compared with that before the treatment. Therefore, the ratio of the lactase activity to the protease activity (protease activity / lactase activity ⁇ 100) of the obtained lactase-containing composition is preferably 0.020% or less, more preferably 0.015% or less. Is particularly preferably 0.010% or less. The lower the protease ratio, the better. Therefore, the lower limit is not particularly limited, but is 0 (for example, when protease activity is not detected).
- the lactase activity contained in the flow-through obtained by the treatment is preferably 100 to 250,000 U / mL, more preferably 500 to 120,000 U / mL, and further preferably 2,500 to 60,000 U / mL.
- the protease activity contained in the passing liquid obtained by the treatment is preferably 100 U / mL or less, more preferably 50 U / mL or less, and further preferably 25 U / mL or less. Since the protease activity is preferably as low as possible, the lower limit is not particularly limited, but is, for example, 0.
- the passing liquid obtained by the above treatment can be further purified by ammonium sulfate fractionation, affinity chromatography, hydrophobic chromatography or the like, if necessary, and pulverized by freeze drying or spray drying.
- step (1) and step (2) of the present invention are preferably carried out under conditions that do not lose lactase activity, for example, at 1 to 30 ° C.
- the lactase-containing composition obtained by the present invention has a reduced protease content as described above, preferably the ratio of lactase activity to protease activity is 0.020% or less, more preferably 0.015% or less. And more preferably 0.010%. Since the lactase-containing composition of the present invention has extremely low protease activity, it does not degrade milk protein even when milk is added to the lactase composition, and it does not precipitate even when added to milk and stored for a long time. This produces a completely unexpected effect that does not cause off-flavor of milk beverages and improves the touch of the resulting dairy product.
- the effect of improving the touch is completely different from the off-flavor reducing effect, and is completely different from the effects such as sweetness and bitterness.
- production suppression effect is specifically, the said lactase containing composition is made to contain 0.1 mass% in milk, and the processing milk after leaving still at 30 degreeC for 3 months is 20,000g for 10 minutes. It can be confirmed that the value obtained by dividing the mass of the precipitate obtained by centrifugation by the weight of the treated milk is 12% or less.
- the lactase-containing composition of the present invention can be widely used for various dairy products.
- the dairy product include milk beverages such as milk, fermented milk, ice cream, milk jam and the like.
- Milk drink is a raw material for fermented milk such as yogurt.
- Milk beverages include those before sterilization and those after sterilization.
- the lactase-containing composition can be added before or after sterilization according to the law.
- Specific ingredients for milk beverages include water, raw milk, pasteurized milk, skim milk, whole milk powder, skim milk powder, buttermilk, butter, cream, whey protein concentrate (WPC), whey protein isolate (WPI) ), ⁇ (alpha) -La, ⁇ (beta) -Lg, and the like.
- WPC whey protein concentrate
- WPI whey protein isolate
- ⁇ (alpha) -La, ⁇ (beta) -Lg Prewarmed gelatin or the like may be added as appropriate.
- Raw material milk is publicly known and may be prepared according to a publicly known method. As a raw material of the milk beverage in the present invention, it is preferable to contain milk. You may use the raw material of a milk drink which consists of 100% of milk
- “Fermented milk” may be any of “fermented milk”, “dairy lactic acid bacteria beverage”, and “lactic acid bacteria beverage” defined by the ministerial ordinance such as yogurt and milk.
- plain yogurt is manufactured by filling a raw material in a container and then fermenting it (post-fermentation).
- soft yogurt and drink yogurt are manufactured by filling fermented fermented milk into a container (pre-fermentation) after atomization or homogenization.
- the lactase-containing composition of the present invention can be used for both post-fermentation and pre-fermentation.
- As a raw material of fermented milk it is preferable to contain milk.
- the amount of the lactase-containing composition to be included in the dairy product varies depending on the type of dairy product.
- the proportion of protease contained in the dairy product may be 0.02% or less.
- a preferable use of the dairy product using the present invention includes a dairy product (for example, long-life milk) containing the lactase contained in the lactase-containing composition in an active state without being deactivated.
- a dairy product for example, long-life milk
- the lactase-containing composition contains a protease, so that the protease tends to act and the off-flavor tends to occur as the storage period of long-life milk becomes longer.
- the blank For the blank, take 0.5 mL of the diluted enzyme sample in a test tube, add 0.5 mL of the same buffer and mix, then add 2.0 mL of the reaction stop solution and incubate at 37 ° C. for 3 minutes. Add and mix 0.1 mL of ONPG solution that has been kept warm at 37 ° C in advance, and keep warm exactly at 37 ° C for 1 minute. The absorbance at 420 nm of each reaction solution is measured using distilled water as a control, and the value obtained by subtracting the absorbance of the blank is taken as the measured value.
- One unit of lactase activity is the amount of enzyme required to change the measured value by 1 per 10 minutes.
- the filter is allowed to stand in a thermostatic bath for 30 minutes, and then naturally filtered using a filter paper (filter paper No. 4A manufactured by Advantech Toyo Co., Ltd.).
- a filter paper filter paper No. 4A manufactured by Advantech Toyo Co., Ltd.
- For the blank take 0.5 mL of the diluted enzyme sample in a test tube, add 2.5 mL of the reaction stop solution, add 2.5 mL of the substrate solution, mix the mixture, and leave it in a constant temperature bath for 30 minutes, and then filter paper (Advantech). Natural filtration is performed using Toyo Corporation filter paper No. 4A).
- the absorbance at 275 nm of each reaction solution is measured using distilled water as a control, and the value obtained by subtracting the blank absorbance is taken as the measured value.
- a standard line is obtained from the tyrosine dissolved so as to have the same reaction solution composition, and the tyrosine concentration of each measurement value is obtained.
- One unit of protease activity is the amount of enzyme necessary to liberate 1 ⁇ g of tyrosine per 10 minutes.
- Example 1 (Preparation of lactase preparation with reduced protease using weak anion exchange groups) 10 mL of GODO-YNL (Lactase activity 5000 U / mL, Lactase activity 5000 g / L, manufactured by Godo Seisei Co., Ltd.) diluted 10-fold with 20 mM KH 2 PO 4 -NaOH buffer solution (pH 6.5, 25 mS / cm) containing 0.2 M KCl. Protease activity ratio per lactase activity (hereinafter referred to as “protease ratio” 0.043%) was passed through QyuSpeed D (capacity 0.6 mL) manufactured by Asahi Kasei Co., Ltd.
- QyuSpeed D Capacity 0.6 mL
- the ratio of protease in the lactase preparation after recovery was reduced from 0.043% to 0.0084% (Table 1), where the lactase yield refers to the total lactase activity after treatment before treatment. The value divided by the total lactase activity is multiplied by 100.
- the lactase yield is practically the lowest at 80% or more. The required level is 85% or more, which is practically less problematic, and preferably 90% or more.
- Example 2 (Preparation of lactase preparation with reduced protease using strong anion exchange groups) 10 mL of GODO-YNL (lactase activity 5000 U / mL, protease ratio 0.043%) diluted 10-fold with 20 mM KH 2 PO 4 -NaOH buffer (pH 6.5, 25 mS / cm) containing 0.2 M KCl The solution was passed through Mustang Q (Acrodisc Unit, pore size 0.8 ⁇ m, diameter 25 mm, manufactured by Pole) having a strong anion exchange membrane. Even when strong ion exchange groups were used, the protease ratio after recovery was reduced from 0.043% to 0.019% (Table 2).
- Example 3 (Examination of electrical conductivity) 10 mL of GODO-YNL diluted 10-fold with 20 mM KH 2 PO 4 -NaOH buffer (pH 6.5, 2-45 mS / cm) containing 0-0.4 M KCl (lactase activity 5000 U / mL, protease ratio 0. 043%) was passed in the same manner as in Example 1. Since the lactase preparation after the recovery had low electrical conductivity (less than 20 mS / cm), lactase itself was adsorbed on the ion exchange group, and therefore, it was combined with the value of Table 1 as a result of Example 1 to 20 mS / cm. (0.2M) or more, the lactase yield was 90% or more. The protease ratio was significantly reduced from 0.043% before the treatment (Table 3).
- Example 4 Degradation of milk protein by lactase-containing composition
- the sample before the ion exchange treatment and the sample after the ion exchange treatment were mixed, and a lactase-containing composition was prepared so that the lactase activity was 5000 U / mL and the protease ratio was 0.0079% to 0.043%. It was added so that it might become 0.3 mL with respect to 30 mL commercially available milk (component non-adjusted milk), and it left still at 30 degreeC for 3 months.
- the casein band was degraded according to the protease ratio as compared with untreated milk.
- ⁇ -casein is clear, and the band could not be confirmed when the protease ratio was 0.028% or more.
- Each treated milk after 3 months tended to have reduced off-flavor and improved storage stability as the protease ratio decreased. It was confirmed that there was no problem of off-flavor and storage stability for the protease ratio of 0.02% or less.
- Example 5 (Degradation of milk protein by protease level)
- curd was confirmed under the container that had been allowed to stand. As shown in FIG. 2, they had significantly less precipitate when the protease ratio was 0.020% or less.
- the milk treated with a lactase preparation having a protease ratio of 0.020% or less was surprisingly good in taste and taste, the protease ratio in the lactase preparation that does not affect milk protein is It became clear that 0.020% or less is desirable.
- the precipitation ratio mentioned here is a value obtained by multiplying the value obtained by dividing the wet weight of the precipitate generated in lactase-treated milk by the weight of lactase-treated milk by 100.
- the protease ratio By paying attention to the protease ratio, it has been found that, in addition to the reduction of off-flavor and the improvement of storage stability, it also improves the good touch of the tongue, which is a new effect. Since the good touch of the tongue can only be confirmed by actually eating it, it is completely different from the off-flavor that can be judged by smell and the storage stability that can be judged by smell and vision. It is. Therefore, the good touch of the tongue is recognized by those skilled in the art as an effect different from off-flavor or storage stability. The reason why the touch of the tongue can be improved in this way is presumed to be because the decomposition of casein is prevented by paying attention to the protease ratio. Furthermore, since lactose can be decomposed to prevent precipitation of lactose at the time of concentration or at low temperatures, the present technology can also be applied to condensed milk and ice cream.
- the good touch of the tongue can be improved by setting the protease ratio to 0.02% or less, it is expected that the good touch will be improved. It has been suggested that it can be applied to uses such as cosmetics and baths containing milk components, taking advantage of the good touch.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Dairy Products (AREA)
- Enzymes And Modification Thereof (AREA)
- Confectionery (AREA)
Abstract
Description
また、本発明の課題は、プロテアーゼ含有量が低減され、乳飲料を使用した乳製品への配合に適したラクターゼ含有組成物、及び当該ラクターゼ含有組成物を配合した乳製品を提供することにある。
[2]ラクターゼ及びプロテアーゼを含有する組成物が、微生物が産生するラクターゼ含有組成物である[1]記載の製造法。
[3]塩含有水溶液が、無機酸塩水溶液である[1]又は[2]記載の製造法。
[4]イオン交換樹脂が、陰イオン交換樹脂である[1]~[3]のいずれかに記載の製造法。
[5]イオン交換樹脂が、陰イオン交換樹脂膜である[1]~[4]のいずれかに記載の製造法。
[6]得られるラクターゼ含有組成物が、ラクターゼ活性とプロテアーゼ活性との比(プロテアーゼ/ラクターゼ)が、0.02%以下である[1]~[5]のいずれかに記載の製造法。
[7]ラクターゼ活性とプロテアーゼ活性との比(プロテアーゼ活性÷ラクターゼ活性×100)が0.02%以下であるラクターゼ含有組成物。
[8][1]~[5]のいずれかの方法により得られたものである[7]記載のラクターゼ含有組成物。
[9]当該ラクターゼ含有組成物を牛乳に0.1質量%含有させ、30℃で3ヶ月間静置した後の処理乳を、20,000gで10分間遠心分離することによって得られる沈殿の質量を処理乳の重量で除した値が12%以下である[7]又は[8]記載のラクターゼ含有組成物。
[10][7]~[9]のいずれかに記載のラクターゼ含有組成物を配合した乳製品。
また、本発明により得られたラクターゼ含有組成物は、ラクターゼ活性とプロテアーゼ活性との比が0.02%以下であり、プロテアーゼ活性が顕著に低減しているとともに、ミルクタンパク質を分解せず、乳に添加して長期間保存しても沈殿を生じ難くなり、乳飲料のオフフレーバーを発生させず、かつ得られる乳製品の舌触りが向上するという全く予想外の効果が得られる。
本発明に使用されるラクターゼは、後述する特定の塩水溶液の存在下において、陰イオン交換樹脂に実質的に吸着しない。実質的に吸着しないとは、ラクターゼ収率が80%以上であることをいい、85%以上であることが好ましく、90%以上であることがさらに好ましい。ラクターゼ収率は高いほど好ましいため、上限は特に限定されないが、例えば100%である。ここで言うラクターゼ収率とは、イオン交換樹脂処理後の総ラクターゼ活性をイオン交換樹脂処理前(塩含有水溶液を添加したもの)の総ラクターゼ活性で除した値に100を乗じた値である。
原料ラクターゼ含有組成物に含まれるプロテアーゼは、後述する特定の塩水溶液の存在下において、陰イオン交換樹脂に吸着しやすい性質を有し、特に弱塩基性陰イオン交換樹脂に吸着する性質を有する。したがって、後述する特定の塩水溶液に溶解したプロテアーゼを陰イオン交換樹脂に吸着させれば、当該プロテアーゼは当該陰イオン交換樹脂に吸着したままの状態を維持する。
原料ラクターゼ含有組成物が液状である場合、液状物である原料ラクターゼ含有組成物100質量部に対し、塩水溶液を10質量部~9900質量部加えればよい。好ましくは、100質量部~9900質量部である。添加する塩水溶液が少ないと、好ましい範囲の電気伝導率が得られにくいため、本発明の効果が得られにくい。添加する塩水溶液が多いと、処理時間がかかり煩雑となる問題がある。
原料ラクターゼ含有組成物が固体状である場合、固形物である原料ラクターゼ含有組成物100質量部に対し、塩水溶液を10質量部~9900質量部加えればよい。好ましくは、100質量部~9900質量部である。添加する塩水溶液が少ないと、好ましい範囲の電気伝導率が得られにくいため、本発明の効果が得られにくい。添加する塩水溶液が多いと、処理時間がかかり煩雑となる問題がある。原料ラクターゼ含有組成物が固体状である場合、塩水溶液を添加することによって当該ラクターゼ含有組成物が均一に溶解または分散していることが好ましい。
前記処理により得られた通過液に含まれるプロテアーゼ活性は、100U/mL以下が好ましく、50U/mL以下がより好ましく、25U/mL以下がさらに好ましい。当該プロテアーゼ活性は低いほど好ましいため下限値は特に限定されないが、例えば0である。
本発明のラクターゼ含有組成物は、プロテアーゼ活性が極めて低減しているため、当該ラクターゼ組成物に乳を添加してもミルクタンパク質を分解せず、また乳に添加して長期間保存しても沈殿を生じ難くなり、乳飲料のオフフレーバーを発生させず、かつ得られる乳製品の舌触りが向上するという全く予想外の効果が得られる。ここで、舌触りの向上効果は、オフフレーバー低減効果とは全く異質のものであり、甘さや苦味といった効果とも全く異なるものである。また、沈殿発生抑制効果は、具体的には、当該ラクターゼ含有組成物を牛乳に0.1質量%含有させ、30℃で3ヶ月間静置した後の処理乳を、20,000gで10分間遠心分離することによって得られる沈殿の質量を処理乳の重量で除した値が12%以下であることによって確認できる。
希釈酵素試料0.5mLを試験管に取り、0.1mMとなるように塩化マンガンを加えた100mMのKH2PO4-NaOH緩衝液(pH6.5)0.5mLを加えて混合した後、37℃で3分間保温する。あらかじめ37℃で保温しておいた0.1%のオルト-ニトロフェニル-β-ガラクトシド(ONPG)溶液1.0mLを加えてすばやく混合し、正確に37℃で1分間保温する。0.2Mの炭酸ナトリウム溶液2.0mLを加えてすばやく混合し、反応を停止する。ブランクに関しては、希釈酵素試料0.5mLを試験管に取り、同緩衝液0.5mLを加えて混合した後、反応停止液2.0mLを加え、37℃で3分間保温する。あらかじめ37℃で保温しておいたONPG溶液0.1mLを加えて混合し、正確に37℃で1分間保温する。蒸留水を対照として各反応液の420nmの吸光度を測定し、ブランクの吸光度を差し引いた値を測定値とする。ラクターゼ活性1単位は、10分間あたりに測定値を1変化させるのに必要な酵素量とする。
希釈酵素試料0.5mLを試験管に取り、30℃で3分間保温する。あらかじめ30℃で保温しておいた基質液(0.1mMとなるように塩化マンガンを加えた100mMのKH2PO4-NaOH緩衝液(pH6.5)に溶解した0.6%のカゼイン溶液)2.5mLを加えてすばやく混合し、正確に30℃で60分間保温する。反応停止液(1.8%トリクロル酢酸、1.8%無水酢酸ナトリウム、2%酢酸)2.5mLを加えてすばやく混合し、反応を停止する。そのまま恒温槽中に30分間放置した後、濾紙(アドバンテック東洋株式会社製 濾紙No.4A)を用いて自然濾過を行なう。ブランクに関しては、希釈酵素試料0.5mLを試験管に取り、反応停止液2.5mLを加え、基質液2.5mLを加えて混合し、そのまま恒温槽中に30分間放置した後、濾紙(アドバンテック東洋株式会社製 濾紙No.4A)を用いて自然濾過を行なう。蒸留水を対照として各反応液の275nmの吸光度を測定し、ブランクの吸光度を差し引いた値を測定値とする。同じ反応液組成となるよう溶解したチロシンから標準直線を求め、各測定値のチロシン濃度を求める。プロテアーゼ活性1単位は、10分間あたりにチロシンを1μg遊離させるのに必要な酵素量とする。
(弱陰イオン交換基を用いたプロテアーゼを低減したラクターゼ製剤の調製)
0.2MのKClを含む20mM KH2PO4-NaOH緩衝液 (pH6.5、25mS/cm)で10倍希釈した10mLのGODO-YNL(合同酒精株式会社製 ラクターゼ製剤〔ラクターゼ活性5000U/mL、ラクターゼ活性あたりのプロテアーゼ活性割合(以下、プロテアーゼ割合)0.043%〕を予め同緩衝液でコンディショニングしておいた弱陰イオン交換基を有した旭化成社製 QyuSpeed D(容量0.6mL)に通液した。回収後のラクターゼ製剤のプロテアーゼ割合は、0.043%から0.0084%に減少していた(表1)。ここで言うラクターゼ収率とは処理後の総ラクターゼ活性を処理前の総ラクターゼ活性で除した値に100を乗じた値である。ラクターゼ収率は80%以上であることが実用上最低限要求されるレベルであり、85%以上であることが実用上問題の少ないレベルであり、90%以上であることが好ましい。
(強陰イオン交換基を用いたプロテアーゼを低減したラクターゼ製剤の調製)
0.2MのKClを含む20mM KH2PO4-NaOH緩衝液(pH6.5、25mS/cm)で10倍希釈した10mLのGODO-YNL(ラクターゼ活性5000U/mL、プロテアーゼ割合0.043%)を強陰イオン交換膜を有したMustang Q(ポール社製 Acrodisc Unit、孔径0.8μm、直径25mm)に通液した。強イオン交換基を用いても回収後のプロテアーゼ割合は、0.043%から0.019%に減少していた(表2)。
0~0.4MのKClを含む20mM KH2PO4-NaOH緩衝液 (pH6.5、2~45mS/cm)で10倍希釈した10mLのGODO-YNL(ラクターゼ活性5000U/mL、プロテアーゼ割合0.043%)を実施例1と同様に通液した。回収後のラクターゼ製剤は、電気伝導率が低い時(20mS/cm未満)はラクターゼ自体がイオン交換基に吸着してしまったため、実施例1の結果である表1の値と合わせて20mS/cm(0.2M)以上でラクターゼ収率が90%以上となった。プロテアーゼ割合は、処理前の0.043%から何れも有意に低減していた(表3)。
上記のイオン交換処理前サンプルとイオン交換処理後サンプルを混合し、ラクターゼ活性が5000U/mL、プロテアーゼ割合が0.0079%~0.043%となるようにラクターゼ含有組成物を調製した。それを30mLの市販の牛乳(成分無調整乳)に対して0.3mLとなるように添加し、30℃で3ヶ月間静置した。3ヶ月後の各処離乳をSDS-PAGEに供したところ、図1に示したようにカゼインのバンドが未処理乳と比較してプロテアーゼ割合に従って分解していた。特にκ-カゼインに関しては明らかであり、プロテアーゼ割合が0.028%以上ではそのバンドが確認できなくなっていた。
3ヶ月後の各処理乳はプロテアーゼ割合が減少するにつれ、オフフレーバーが減少し、保存安定性が向上する傾向にあった。プロテアーゼ割合が0.02%以下であったものについてオフフレーバー及び保存安定性の問題がないことが確認された。
実施例4のラクターゼ処理乳においては、静置していた容器の下に凝乳が確認された。それらは、図2に示したようにプロテアーゼ割合0.020%以下の時には顕著に沈殿物が少なかった。さらに、プロテアーゼ割合が0.020%以下のラクターゼ製剤で処理した牛乳は、驚くべきことに舌触りが良くて味質も良好であったので、乳タンパクに影響を及ぼさないラクターゼ製剤中のプロテアーゼ割合は0.020%以下が望ましいことが明らかとなった。
このように舌触りの良さを向上させることができるのは、プロテアーゼ割合に注目することによって、カゼインの分解を防ぐからであると推測される。さらに、ラクトースを分解することで、濃縮時や低温時におけるラクトースの析出を防ぐことができるため、本技術は練乳やアイスクリームにも応用可能である。
Claims (10)
- ラクターゼ及びプロテアーゼを含有する組成物を電気伝導率2~45mS/cmの塩含有水溶液に溶解し、得られた溶液をイオン交換樹脂に接触させ、イオン交換樹脂に吸着しない画分を採取することを特徴とする、プロテアーゼ含有量が低減したラクターゼ含有組成物の製造法。
- ラクターゼ及びプロテアーゼを含有する組成物が、微生物が産生するラクターゼ含有組成物である請求項1記載の製造法。
- 塩含有水溶液が、無機酸塩水溶液である請求項1又は2記載の製造法。
- イオン交換樹脂が、陰イオン交換樹脂である請求項1~3のいずれかに記載の製造法。
- イオン交換樹脂が、陰イオン交換樹脂膜である請求項1~4のいずれかに記載の製造法。
- 得られるラクターゼ含有組成物が、ラクターゼ活性とプロテアーゼ活性との比(プロテアーゼ活性÷ラクターゼ活性×100)が、0.02%以下である請求項1~5のいずれかに記載の製造法。
- ラクターゼ活性とプロテアーゼ活性との比(プロテアーゼ活性÷ラクターゼ活性×100)が0.02%以下であるラクターゼ含有組成物。
- 請求項1~5のいずれかの方法により得られたものである請求項7記載のラクターゼ含有組成物。
- 前記ラクターゼ含有組成物を牛乳に0.1質量%含有させ、30℃で3ヶ月間静置した後の処理乳を、20,000gで10分間遠心分離することによって得られる沈殿の質量を処理乳の重量で除した値が12%以下である請求項7又は8記載のラクターゼ含有組成物。
- 請求項7~9のいずれかに記載のラクターゼ含有組成物を配合した乳製品。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK14798365.4T DK2998395T3 (da) | 2013-05-13 | 2014-05-12 | Fremgangsmåde til fremstilling af lactaseholdige sammensætninger |
EP14798365.4A EP2998395B1 (en) | 2013-05-13 | 2014-05-12 | Method for producing lactase-containing compositions |
US14/890,547 US9848614B2 (en) | 2013-05-13 | 2014-05-12 | Method for producing lactase-containing composition |
JP2015517063A JP6341911B2 (ja) | 2013-05-13 | 2014-05-12 | ラクターゼ含有組成物の製造法 |
AU2014266373A AU2014266373A1 (en) | 2013-05-13 | 2014-05-12 | Method for producing lactase-containing composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013101077 | 2013-05-13 | ||
JP2013-101077 | 2013-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014185364A1 true WO2014185364A1 (ja) | 2014-11-20 |
Family
ID=51898342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2014/062552 WO2014185364A1 (ja) | 2013-05-13 | 2014-05-12 | ラクターゼ含有組成物の製造法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9848614B2 (ja) |
EP (1) | EP2998395B1 (ja) |
JP (1) | JP6341911B2 (ja) |
AU (1) | AU2014266373A1 (ja) |
DK (1) | DK2998395T3 (ja) |
WO (1) | WO2014185364A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016194782A1 (ja) * | 2015-05-29 | 2016-12-08 | 天野エンザイム株式会社 | 菌体内酵素の調製方法 |
WO2018079758A1 (ja) * | 2016-10-31 | 2018-05-03 | 合同酒精株式会社 | 発酵乳製品の製造方法及び酵素含有組成物 |
JPWO2017159723A1 (ja) * | 2016-03-16 | 2019-01-24 | 合同酒精株式会社 | プロテイナーゼb並びにその性質を利用したラクターゼ溶液及びその製造方法。 |
WO2023008491A1 (ja) * | 2021-07-27 | 2023-02-02 | 合同酒精株式会社 | 酵素含有組成物、乳の製造方法及び発酵乳の製造方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3435771A1 (en) * | 2016-03-31 | 2019-02-06 | DSM IP Assets B.V. | Enzyme composition and preparation of a dairy product with improved properties |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5176459A (ja) * | 1974-12-25 | 1976-07-02 | Kogyo Gijutsuin | |
JPS53148591A (en) * | 1977-05-31 | 1978-12-25 | Daiwa Kasei Kk | Production of novel lactase |
JP2004534527A (ja) | 2001-04-04 | 2004-11-18 | デーエスエム イーペー アセッツ ベスローテン フェンノートシャップ | 精製ラクターゼ |
JP2009517061A (ja) | 2005-11-28 | 2009-04-30 | ディーエスエム アイピー アセッツ ビー.ブイ. | クリーンな味を産み出す酵素調製物 |
WO2011033633A1 (ja) * | 2009-09-17 | 2011-03-24 | 合同酒精株式会社 | ラクターゼ製剤 |
WO2012124668A1 (ja) * | 2011-03-14 | 2012-09-20 | 合同酒精株式会社 | アリールスルファターゼの活性測定方法 |
-
2014
- 2014-05-12 AU AU2014266373A patent/AU2014266373A1/en not_active Abandoned
- 2014-05-12 JP JP2015517063A patent/JP6341911B2/ja not_active Expired - Fee Related
- 2014-05-12 WO PCT/JP2014/062552 patent/WO2014185364A1/ja active Application Filing
- 2014-05-12 US US14/890,547 patent/US9848614B2/en not_active Expired - Fee Related
- 2014-05-12 DK DK14798365.4T patent/DK2998395T3/da active
- 2014-05-12 EP EP14798365.4A patent/EP2998395B1/en not_active Not-in-force
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5176459A (ja) * | 1974-12-25 | 1976-07-02 | Kogyo Gijutsuin | |
JPS53148591A (en) * | 1977-05-31 | 1978-12-25 | Daiwa Kasei Kk | Production of novel lactase |
JP2004534527A (ja) | 2001-04-04 | 2004-11-18 | デーエスエム イーペー アセッツ ベスローテン フェンノートシャップ | 精製ラクターゼ |
JP2009517061A (ja) | 2005-11-28 | 2009-04-30 | ディーエスエム アイピー アセッツ ビー.ブイ. | クリーンな味を産み出す酵素調製物 |
WO2011033633A1 (ja) * | 2009-09-17 | 2011-03-24 | 合同酒精株式会社 | ラクターゼ製剤 |
WO2012124668A1 (ja) * | 2011-03-14 | 2012-09-20 | 合同酒精株式会社 | アリールスルファターゼの活性測定方法 |
Non-Patent Citations (2)
Title |
---|
MILCHWISSENSCHAFT, vol. 62, no. 4, 2007, pages 410 - 414 |
YEAST, vol. 15, no. 14, 1999, pages 1437 - 1448 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016194782A1 (ja) * | 2015-05-29 | 2016-12-08 | 天野エンザイム株式会社 | 菌体内酵素の調製方法 |
JPWO2016194782A1 (ja) * | 2015-05-29 | 2018-03-22 | 天野エンザイム株式会社 | 菌体内酵素の調製方法 |
JPWO2017159723A1 (ja) * | 2016-03-16 | 2019-01-24 | 合同酒精株式会社 | プロテイナーゼb並びにその性質を利用したラクターゼ溶液及びその製造方法。 |
WO2018079758A1 (ja) * | 2016-10-31 | 2018-05-03 | 合同酒精株式会社 | 発酵乳製品の製造方法及び酵素含有組成物 |
JPWO2018079758A1 (ja) * | 2016-10-31 | 2019-11-21 | 合同酒精株式会社 | 発酵乳製品の製造方法及び酵素含有組成物 |
JP7401970B2 (ja) | 2016-10-31 | 2023-12-20 | 合同酒精株式会社 | 発酵乳製品の製造方法及び酵素含有組成物 |
WO2023008491A1 (ja) * | 2021-07-27 | 2023-02-02 | 合同酒精株式会社 | 酵素含有組成物、乳の製造方法及び発酵乳の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
DK2998395T3 (da) | 2019-05-20 |
US9848614B2 (en) | 2017-12-26 |
JP6341911B2 (ja) | 2018-06-13 |
AU2014266373A1 (en) | 2015-12-03 |
EP2998395A1 (en) | 2016-03-23 |
EP2998395B1 (en) | 2019-04-10 |
US20160081361A1 (en) | 2016-03-24 |
JPWO2014185364A1 (ja) | 2017-02-23 |
EP2998395A4 (en) | 2016-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6341911B2 (ja) | ラクターゼ含有組成物の製造法 | |
JPWO2009008362A1 (ja) | シアル酸化合物含有組成物の製造方法 | |
AU2009224095B2 (en) | Process for isolating sialic acid containing oligosaccharides, and the compositions containing sialic acid containing oligosaccharides obtainable thereby | |
JPH0319654A (ja) | ホエー蛋白質を含む出発原料からのラクトグロブリン除去法 | |
JP2000350551A (ja) | 脱塩を目的とするホエーの処理方法 | |
CN112646847A (zh) | 一种半乳糖葡萄糖混合物的制备方法 | |
JPH0131865B2 (ja) | ||
JP3946747B2 (ja) | ラクトパーオキシダーゼの製造方法 | |
Paladii et al. | Whey: Review. Part 2. Treatment Processes and Methods | |
JPS60251867A (ja) | 乳酸菌飲料の製造法 | |
CN105399816A (zh) | 一种从转基因山羊乳汁中分离人乳铁蛋白的方法 | |
EP2873329A1 (en) | Process of whey protein separation from milk medium and apparatus for its implementation | |
Mohammad et al. | Influence of some polyvalent organic acids and salts on the colloidal stability of milk | |
CN107325978A (zh) | 蛋白质谷氨酰胺酶产生菌及发酵产物的制备与应用 | |
JP3411965B2 (ja) | ポリアミン含有組成物の製造方法 | |
CN112655768B (zh) | 含乳铁蛋白奶粉的制备方法 | |
JPS63192386A (ja) | ストレプトミセス科からの細菌溶解酵素生成物およびその製法 | |
JP2013048631A (ja) | カルニチンを用いた調製粉乳または機能性健康原料 | |
EP3228704A1 (en) | Lactase solution and dairy product using same | |
JPS59220153A (ja) | 乳酸発酵飲料の製造方法 | |
JP2024511136A (ja) | ラクトースに富む液体組成物を製造するために乳タンパク質組成物を加工する方法 | |
JPH0117655B2 (ja) | ||
JPH02107156A (ja) | 乳ミネラル濃縮物の製造方法 | |
JPH0513609B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14798365 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2015517063 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14890547 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014798365 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2014266373 Country of ref document: AU Date of ref document: 20140512 Kind code of ref document: A |